2020
|
Invention
|
Process for the manufacture of snac (salcaprozate sodium).
Disclosed are improved methods for th... |
|
Invention
|
Crystalline polymorphic forms of monosodium n-[-8-(2-hydroxybenzoyl)amino]caprylate. The present ... |
|
Invention
|
Oral b12 therapy.
Methods of normalizing vitamin B12 levels in patients with low vitamin B12 and... |
2018
|
Invention
|
Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent.
This... |
|
Invention
|
Formulations for delivering insulin.
Oral insulin formulations and processes for preparing oral ... |
2017
|
Invention
|
Gastric retention and controlled release delivery system.
The present invention relates to gastr... |
|
Invention
|
Arylsulfanyl compounds and compositions for delivering active agents.
Compounds and compositions... |
|
Invention
|
Antidiabetic oral insulin biguanide combination.
Pharmaceutical dosage forms, comprising insulin... |
2016
|
Invention
|
Compositions for delivering peptide yy and pyy agonists.
The present invention provides a compos... |
2015
|
Invention
|
Method for administering glp-1 molecules.
The invention relates to formulations that demonstrate... |
2013
|
Invention
|
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (glp-1) comp... |
|
Invention
|
Acyclovir formulations. The present invention relates to an acyclovir formulation having improved... |
2012
|
Invention
|
12 deficiency. 12 therapy. |
|
Invention
|
Acyclovir formulations.
The present invention relates to acyclovir formulations having improved ... |
|
Invention
|
Disodium salts, monohydrates, and ethanol solvates for delivering active agents. The inventors ha... |
|
Invention
|
Phenylalkylcarboxylic acid delivery agents.
The present invention provides phenylalkylcarboxylic... |
2011
|
Invention
|
Fast acting naratriptan composition. The present invention relates to pharmaceutical compositions... |
|
Invention
|
Oral iron deficiency therapy. Methods of normalizing iron levels, treating iron deficiency and di... |
|
Invention
|
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (glp)-1 comp... |
|
Invention
|
Formulation comprising glp-1. The invention relates to formulations that demonstrate the feasibil... |
2010
|
Invention
|
Fast-acting naproxen composition with reduced gastrointestinal effects.
The present invention re... |
2009
|
Invention
|
Oral insulin therapies and protocol. Methods for treating impaired glucose tolerance and early an... |
|
Invention
|
Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers. Th... |
|
Invention
|
Oral glp-1 formulations. The present invention provides pharmaceutical compositions comprising of... |
|
Invention
|
Compositions for delivering parathyroid hormone and calcitonin.
The present invention relates to... |
|
Invention
|
Compounds and compositions for delivering active agents. Carrier compounds and compositions there... |
|
Invention
|
Method for administering glp-1 molecules. The invention relates to formulations that demonstrate ... |
2008
|
Invention
|
Method of treating vitamin b12 deficiency. 12 therapy. |
|
Invention
|
Allyloxy and alkyloxy benzoic acid delivery agents. The present invention relates to pharmaceutic... |
|
Invention
|
Compounds having a cyclic moiety and compositions for delivering active agents. Compounds compris... |
2007
|
Invention
|
acyclovir formulations.
The present invention relates to acyclovir formulations having improved... |
|
Invention
|
Synthesis of propyl phenoxy ethers and use as delivery agents.
The present invention provides pr... |
|
Invention
|
Pharmaceutical formulations for the treatment of alzheimer's disease. The present invention relat... |
|
Invention
|
Gallium nitrate formulations. The present invention relates to stable pharmaceutical formulations... |
|
Invention
|
Formulations for delivering insulin. Oral insulin formulations and processes for preparing oral i... |
2006
|
Invention
|
Cyclopropyl compounds and compositions for delivering active agents. Compounds and compositions f... |
2005
|
Invention
|
Antidiabetic oral insulin-biguanide combination.
Pharmaceutical dosage forms, comprising insulin... |